NEW REPORT Americans will spend $137B on Keytruda during its extended monopoly
I-MAK’s response to the senseless killings of Black people with impunity
As more countries around the world reject unmerited patents for Sovaldi®, I-MAK Files Two New U.S. Patent Challenges on Gilead’s Hepatitis C Portfolio
Argentina Rejects Key Patent on Hepatitis C Drug
Country Watch: Nigeria
Partner with us now to build a more just and equitable medicine system for all.